1. Phase III comparison of concurrent chemotherapy plus radiotherapy (CT/radiotherapy) and CT/radiotherapy followed by surgical resection for stage IIIA(pN2) non-small cell lung cancer (NSCLS): initial results from intergroup trial 0139 (RTOG 93-09);Albain,2003
2. Neoadjuvant therapy with docetaxel and cisplatin in patients with non-small cell lung cancer (NSCLC), stage IIIA, pN2: a large phase II study with 59 months of follow-up;Betticher;Lung Cancer,2005
3. Preoperative chemotherapy and concurrent radio-chemotherapy followed by definitive surgery (‘Trimodality’) in patients with locally advanced inoperable non-small-cell lung cancer stage IIIA/IIIB — 20-year-survival results;Gauler;Lung Cancer,2005
4. Phase III study of concurrent chemotherapy and radiotherapy (CT/RT) vs CT/RT followed by surgical resection for stage IIIA(pN2) non-small cell lung cancer (NSCLC): Outcomes update of North American Intergroup 0139 (RTOG 9309);Albain;J Clin Oncol,2005
5. A randomized trial of radical surgery (S) versus thoracic radiotherapy (TRT) in patients with stage IIIA-N2 non-small cell lung cancer (NSCLC) after response to induction chemotherapy (ICT) (EORTC 08941);van Meerbeeck;J Clin Oncol,2005